Literature DB >> 31312650

Immunotherapy: New Options in Gastrointestinal Cancers?

Andrea Tannapfel1, Anke Reinacher-Schick2, Ulrich Hacker3, Sylvie Lorenzen4, Markus Möhler5, Arndt Vogel6.   

Abstract

Entities:  

Year:  2019        PMID: 31312650      PMCID: PMC6597929          DOI: 10.1159/000497293

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


× No keyword cloud information.
  7 in total

Review 1.  Comprehensive analysis of the clinical immuno-oncology landscape.

Authors:  J Tang; A Shalabi; V M Hubbard-Lucey
Journal:  Ann Oncol       Date:  2018-01-01       Impact factor: 32.976

2.  Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.

Authors:  Bernhard Mlecnik; Gabriela Bindea; Helen K Angell; Pauline Maby; Mihaela Angelova; David Tougeron; Sarah E Church; Lucie Lafontaine; Maria Fischer; Tessa Fredriksen; Maristella Sasso; Amélie M Bilocq; Amos Kirilovsky; Anna C Obenauf; Mohamad Hamieh; Anne Berger; Patrick Bruneval; Jean-Jacques Tuech; Jean-Christophe Sabourin; Florence Le Pessot; Jacques Mauillon; Arash Rafii; Pierre Laurent-Puig; Michael R Speicher; Zlatko Trajanoski; Pierre Michel; Richard Sesboüe; Thierry Frebourg; Franck Pagès; Viia Valge-Archer; Jean-Baptiste Latouche; Jérôme Galon
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

3.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Authors:  Dung T Le; Jennifer N Durham; Kellie N Smith; Hao Wang; Bjarne R Bartlett; Laveet K Aulakh; Steve Lu; Holly Kemberling; Cara Wilt; Brandon S Luber; Fay Wong; Nilofer S Azad; Agnieszka A Rucki; Dan Laheru; Ross Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Tim F Greten; Austin G Duffy; Kristen K Ciombor; Aleksandra D Eyring; Bao H Lam; Andrew Joe; S Peter Kang; Matthias Holdhoff; Ludmila Danilova; Leslie Cope; Christian Meyer; Shibin Zhou; Richard M Goldberg; Deborah K Armstrong; Katherine M Bever; Amanda N Fader; Janis Taube; Franck Housseau; David Spetzler; Nianqing Xiao; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; James R Eshleman; Bert Vogelstein; Robert A Anders; Luis A Diaz
Journal:  Science       Date:  2017-06-08       Impact factor: 47.728

4.  Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Chun Jye Lim; Yun Hua Lee; Salvatore Albani; Valerie Chew; Lu Pan; Liyun Lai; Camillus Chua; Martin Wasser; Tony Kiat Hon Lim; Joe Yeong; Han Chong Toh; Ser Yee Lee; Chung Yip Chan; Brian Kp Goh; Alexander Chung; Mathias Heikenwälder; Irene Ol Ng; Pierce Chow
Journal:  Gut       Date:  2018-07-03       Impact factor: 23.059

5.  Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.

Authors:  Seung Tae Kim; Razvan Cristescu; Adam J Bass; Kyoung-Mee Kim; Justin I Odegaard; Kyung Kim; Xiao Qiao Liu; Xinwei Sher; Hun Jung; Mijin Lee; Sujin Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Hyuk Lee; Mingew Choi; AmirAli Talasaz; Peter Soonmo Kang; Jonathan Cheng; Andrey Loboda; Jeeyun Lee; Won Ki Kang
Journal:  Nat Med       Date:  2018-07-16       Impact factor: 53.440

6.  FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1.

Authors:  Lola Fashoyin-Aje; Martha Donoghue; Huanyu Chen; Kun He; Janaki Veeraraghavan; Kirsten B Goldberg; Patricia Keegan; Amy E McKee; Richard Pazdur
Journal:  Oncologist       Date:  2018-08-17

Review 7.  The expansion of targetable biomarkers for CAR T cell therapy.

Authors:  Michelle H Townsend; Gajendra Shrestha; Richard A Robison; Kim L O'Neill
Journal:  J Exp Clin Cancer Res       Date:  2018-07-21
  7 in total
  1 in total

Review 1.  A Review of Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors of the Gastrointestinal Tract.

Authors:  Xuqiang Liao; Gao Li; Renzhong Cai; Ru Chen
Journal:  Med Sci Monit       Date:  2022-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.